Stay updated on ACTT: Remdesivir for Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.

Latest updates to the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page
- ChecktodayChange DetectedThe Locations section was updated with new site entries (US states and international locations) and the removal of several previously listed sites. A new revision tag Revision: v3.3.3 appears to accompany the changes.SummaryDifference2%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedPublications are described as automatically filled from PubMed, and a Revision: v3.3.2 note was added. These edits are editorial and do not affect the study content or participation details.SummaryDifference0.1%

- Check29 days agoChange DetectedThe bottom notice about government funding/operating status was removed. The page no longer displays information about potential delays or where to check operating status.SummaryDifference0.2%

- Check51 days agoChange DetectedThe Locations section now lists updated study sites across multiple countries, with some sites added and others removed. This changes where the trial is recruiting and how to reach the appropriate site for enrollment.SummaryDifference0.2%

- Check72 days agoChange DetectedUpdate includes a new operating status notice and version bump to v3.2.0; removal of the previous v3.1.0 note indicates version update.SummaryDifference1%

- Check80 days agoChange DetectedUpdated page version from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.0%

Stay in the know with updates to ACTT: Remdesivir for Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.